Tiziana Life Sciences Ltd (TLSA)

Tiziana Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Cash & Equivalents	4.01	3.72	1.18
Cash & Short-Term Investments	4.01	3.72	1.18
Cash Growth	7.68%	214.79%	-
Accounts Receivable	3.98	3.61	2.14
Other Receivables	0.1	0.03	3.79
Total Trade Receivables	4.08	3.64	5.93
Other Current Assets	0.46	0.15	0.22
Total Current Assets	8.55	7.51	7.34
Net Property, Plant & Equipment	0.5	0.19	0.29
Long-Term Investments	2.44	3.59	4.55
Total Assets	11.5	11.28	12.18
Accounts Payable	10.46	7.23	6.39
Current Portion of Leases	0.22	0.11	0.14
Unearned Revenue	0.53	-	-
Other Current Liabilities	-0	0.01	0.01
Total Current Liabilities	11.21	7.35	6.54
Long-Term Leases	0.23	-	0.11
Total Long-Term Liabilities	0.23	-	0.11
Total Liabilities	11.44	7.35	6.65
Common Stock	0.12	0.11	0.1
Treasury Stock	-	-	-1.57
Additional Paid-in Capital	164.84	150.36	142.32
Accumulated Other Comprehensive Income	-1.8	-1.71	-1.64
Retained Earnings	-163.11	-144.83	-133.68
Shareholders' Equity	0.05	3.94	5.54
Total Liabilities & Equity	11.5	11.28	12.18
Total Debt	0.46	0.11	0.25
Net Cash (Debt)	3.55	3.62	0.94
Net Cash Growth	-1.77%	286.54%	-
Net Cash Per Share	0.15	0.17	0.05
Book Value	0.05	3.94	5.54
Book Value Per Share	0.00	0.18	0.27
Tangible Book Value	0.05	3.94	5.54
Tangible Book Value Per Share	0.00	0.18	0.27

Updated Feb 14, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q